300 related articles for article (PubMed ID: 21249428)
1. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.
Balasubramanyam M; Aravind S; Gokulakrishnan K; Prabu P; Sathishkumar C; Ranjani H; Mohan V
Mol Cell Biochem; 2011 May; 351(1-2):197-205. PubMed ID: 21249428
[TBL] [Abstract][Full Text] [Related]
2. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.
Alipoor B; Ghaedi H; Meshkani R; Omrani MD; Sharifi Z; Golmohammadi T
J Endocrinol Invest; 2018 May; 41(5):557-566. PubMed ID: 29058209
[TBL] [Abstract][Full Text] [Related]
3. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
Al-Rawaf HA; Alghadir AH; Gabr SA
Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study.
Zeinali F; Aghaei Zarch SM; Jahan-Mihan A; Kalantar SM; Vahidi Mehrjardi MY; Fallahzadeh H; Hosseinzadeh M; Rahmanian M; Mozaffari-Khosravi H
PLoS One; 2021; 16(6):e0251697. PubMed ID: 34077450
[TBL] [Abstract][Full Text] [Related]
5. Effect of High MiR-146a Expression on the Inflammatory Reaction in BV2 Cells.
Zhao N; Shen L; Jiang HW; Ma C; Huang YG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):27-32. PubMed ID: 26956852
[TBL] [Abstract][Full Text] [Related]
6. Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1β, and TNFα levels in type 2 diabetes and insulin resistance.
Degirmenci I; Ozbayer C; Kebapci MN; Kurt H; Colak E; Gunes HV
Inflamm Res; 2019 Sep; 68(9):801-814. PubMed ID: 31222667
[TBL] [Abstract][Full Text] [Related]
7. Swimming Impacts on Pancreatic Inflammatory Cytokines, miR-146a and NF-кB Expression Levels in Type-2 Diabetic Rats.
Alipour MR; Yousefzade N; Bavil FM; Naderi R; Ghiasi R
Curr Diabetes Rev; 2020; 16(8):889-894. PubMed ID: 31733638
[TBL] [Abstract][Full Text] [Related]
8. The relationship between NR2E1 and subclinical inflammation in newly diagnosed type 2 diabetic patients.
Sun L; Deng H; He L; Hu X; Huang Q; Xue J; Chen J; Shi X; Xu Y
J Diabetes Complications; 2015; 29(4):589-94. PubMed ID: 25813674
[TBL] [Abstract][Full Text] [Related]
9. Altered immunometabolism at the interface of increased endoplasmic reticulum (ER) stress in patients with type 2 diabetes.
Lenin R; Sankaramoorthy A; Mohan V; Balasubramanyam M
J Leukoc Biol; 2015 Oct; 98(4):615-22. PubMed ID: 26123743
[TBL] [Abstract][Full Text] [Related]
10. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
Mortazavi-Jahromi SS; Ahmadzadeh A; Rezaieyazdi Z; Aslani M; Omidian S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):228-236. PubMed ID: 32223462
[No Abstract] [Full Text] [Related]
11. MicroRNA-146a Ameliorates Inflammation via TRAF6/NF-κB Pathway in Intervertebral Disc Cells.
Lv F; Huang Y; Lv W; Yang L; Li F; Fan J; Sun J
Med Sci Monit; 2017 Feb; 23():659-664. PubMed ID: 28161709
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients.
Baldeón R L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; Freire W; Drexhage HA; Leenen PJ
PLoS One; 2014; 9(12):e115209. PubMed ID: 25500583
[TBL] [Abstract][Full Text] [Related]
13. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes.
Sathishkumar C; Prabu P; Mohan V; Balasubramanyam M
Hum Genomics; 2018 Aug; 12(1):41. PubMed ID: 30139387
[TBL] [Abstract][Full Text] [Related]
14. The role of miR-146a on NF-κB expression level in human umbilical vein endothelial cells under hyperglycemic condition.
Kamali K; Korjan ES; Eftekhar E; Malekzadeh K; Soufi FG
Bratisl Lek Listy; 2016; 117(7):376-80. PubMed ID: 27546538
[TBL] [Abstract][Full Text] [Related]
15. MiR-146a Regulates Inflammatory Infiltration by Macrophages in Polymyositis/Dermatomyositis by Targeting TRAF6 and Affecting IL-17/ICAM-1 Pathway.
Yin Y; Li F; Shi J; Li S; Cai J; Jiang Y
Cell Physiol Biochem; 2016; 40(3-4):486-498. PubMed ID: 27889748
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
[TBL] [Abstract][Full Text] [Related]
17. Expression of miR-18a and miR-34c in circulating monocytes associated with vulnerability to type 2 diabetes mellitus and insulin resistance.
Wang SS; Li YQ; Liang YZ; Dong J; He Y; Zhang L; Yan YX
J Cell Mol Med; 2017 Dec; 21(12):3372-3380. PubMed ID: 28661068
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins.
Park H; Huang X; Lu C; Cairo MS; Zhou X
J Biol Chem; 2015 Jan; 290(5):2831-41. PubMed ID: 25505246
[TBL] [Abstract][Full Text] [Related]
19. Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146.
Yang M; Ye L; Wang B; Gao J; Liu R; Hong J; Wang W; Gu W; Ning G
J Diabetes; 2015 Mar; 7(2):158-65. PubMed ID: 24796653
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.
Carey AL; Bruce CR; Sacchetti M; Anderson MJ; Olsen DB; Saltin B; Hawley JA; Febbraio MA
Diabetologia; 2004 Jun; 47(6):1029-37. PubMed ID: 15168015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
